| |
 |
X-Ceptor Therapeutics, Inc. Patents |
|
Assignee: X-Ceptor Therapeutics, Inc.
Address: San Diego, CA
No. of patents: 4
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 7482366 |
Modulators of LXR |
January 27, 2009 |
| Compounds of the invention, such as compounds of formula (I): ##STR00001## where n, m, A, B, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are defined herein, are useful as modulators of the activity of liver X receptors. Pharmaceutical compositions containing the compounds and m |
| 7115640 |
Heterocyclic modulators of nuclear receptors |
October 3, 2006 |
| Compounds, compositions and methods for modulating the activity of nuclear receptors are provided. In particular, heterocyclic compounds are provided for modulating the activity of farnesoid X receptor (FXR), liver X receptor (LXR) and/or orphan nuclear receptors. In certain embodiments, |
| 6924311 |
Methods for affecting various diseases utilizing LXR compounds |
August 2, 2005 |
| The present invention relates to methods for elevating high density lipoprotein (HDL) plasma levels, decreasing the absorption of dietary cholesterol in the intestine, decreasing the plasma level of low density lipoprotein (LDL), and increasing the conversion of cholesterol to bile a |
| 6696473 |
Heterocyclic modulators of nuclear receptors |
February 24, 2004 |
| Compounds, compositions and methods for modulating the activity of nuclear receptors are provided. In particular, heterocyclic compounds are provided for modulating the activity of farnesoid X receptor (FXR), liver X receptor (LXR) and/or orphan nuclear receptors. In certain embodiments, |
|
|
|
